

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of erythrocyte differentiation (GO:0045647) | 5.10422824 |
| 2 | negative regulation of cell killing (GO:0031342) | 3.69396990 |
| 3 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.69396990 |
| 4 | response to peptidoglycan (GO:0032494) | 3.58744353 |
| 5 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.50854945 |
| 6 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.50854945 |
| 7 | modulation by symbiont of host immune response (GO:0052553) | 3.50854945 |
| 8 | positive regulation by symbiont of host defense response (GO:0052509) | 3.50854945 |
| 9 | modulation by symbiont of host defense response (GO:0052031) | 3.50854945 |
| 10 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.50854945 |
| 11 | mannose metabolic process (GO:0006013) | 3.47923206 |
| 12 | apoptotic process involved in morphogenesis (GO:0060561) | 3.34859841 |
| 13 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.34671825 |
| 14 | positive regulation of histone deacetylation (GO:0031065) | 3.26641340 |
| 15 | response to muramyl dipeptide (GO:0032495) | 3.18569600 |
| 16 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.17949783 |
| 17 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.15330260 |
| 18 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.13867890 |
| 19 | protein localization to endosome (GO:0036010) | 3.13182518 |
| 20 | negative regulation of cell size (GO:0045792) | 3.10411250 |
| 21 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.09945987 |
| 22 | germinal center formation (GO:0002467) | 3.06310338 |
| 23 | regulation of early endosome to late endosome transport (GO:2000641) | 3.05396508 |
| 24 | positive thymic T cell selection (GO:0045059) | 3.03986042 |
| 25 | response to laminar fluid shear stress (GO:0034616) | 3.03826502 |
| 26 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 3.02280931 |
| 27 | thymic T cell selection (GO:0045061) | 2.98456607 |
| 28 | detection of bacterium (GO:0016045) | 2.97703293 |
| 29 | macrophage activation involved in immune response (GO:0002281) | 2.94502057 |
| 30 | modulation by symbiont of host cellular process (GO:0044068) | 2.93330834 |
| 31 | focal adhesion assembly (GO:0048041) | 2.92479556 |
| 32 | cell-substrate adherens junction assembly (GO:0007045) | 2.92479556 |
| 33 | adherens junction assembly (GO:0034333) | 2.92363362 |
| 34 | detection of other organism (GO:0098543) | 2.92033419 |
| 35 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.91140141 |
| 36 | NIK/NF-kappaB signaling (GO:0038061) | 2.89324033 |
| 37 | stress fiber assembly (GO:0043149) | 2.88589780 |
| 38 | modulation by virus of host process (GO:0019054) | 2.84126755 |
| 39 | activation of Rac GTPase activity (GO:0032863) | 2.84087731 |
| 40 | leukocyte aggregation (GO:0070486) | 2.83858884 |
| 41 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.80411214 |
| 42 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.80078437 |
| 43 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.79434865 |
| 44 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.73639618 |
| 45 | regulation of extracellular matrix disassembly (GO:0010715) | 2.73353393 |
| 46 | signal complex assembly (GO:0007172) | 2.72617263 |
| 47 | barbed-end actin filament capping (GO:0051016) | 2.72263957 |
| 48 | positive regulation of myotube differentiation (GO:0010831) | 2.72012967 |
| 49 | regulation of leukocyte degranulation (GO:0043300) | 2.70663091 |
| 50 | negative regulation of necroptotic process (GO:0060546) | 2.69472591 |
| 51 | regulation of necroptotic process (GO:0060544) | 2.67571783 |
| 52 | positive regulation of protein deacetylation (GO:0090312) | 2.62867515 |
| 53 | regulation of ARF GTPase activity (GO:0032312) | 2.60197589 |
| 54 | neutrophil activation involved in immune response (GO:0002283) | 2.58343739 |
| 55 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.57706398 |
| 56 | regulation of gamma-delta T cell activation (GO:0046643) | 2.57423449 |
| 57 | positive regulation of protein dephosphorylation (GO:0035307) | 2.55774452 |
| 58 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.55662460 |
| 59 | activation of MAPKKK activity (GO:0000185) | 2.53298505 |
| 60 | negative regulation of myotube differentiation (GO:0010832) | 2.53035195 |
| 61 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.52508260 |
| 62 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.52393804 |
| 63 | positive regulation of receptor recycling (GO:0001921) | 2.52322283 |
| 64 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.51223710 |
| 65 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.49920207 |
| 66 | detection of external biotic stimulus (GO:0098581) | 2.48396430 |
| 67 | maternal placenta development (GO:0001893) | 2.48115175 |
| 68 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.47272081 |
| 69 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.46954870 |
| 70 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.46890820 |
| 71 | activation of JUN kinase activity (GO:0007257) | 2.46882528 |
| 72 | regulation of mast cell degranulation (GO:0043304) | 2.46703917 |
| 73 | atrioventricular valve morphogenesis (GO:0003181) | 2.45193398 |
| 74 | regulation of chromatin binding (GO:0035561) | 2.45160002 |
| 75 | T cell selection (GO:0045058) | 2.44655719 |
| 76 | response to host defenses (GO:0052200) | 2.43795582 |
| 77 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.43795582 |
| 78 | response to host (GO:0075136) | 2.43795582 |
| 79 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.43265575 |
| 80 | embryonic process involved in female pregnancy (GO:0060136) | 2.42321205 |
| 81 | negative regulation of viral release from host cell (GO:1902187) | 2.42197733 |
| 82 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.41682644 |
| 83 | semaphorin-plexin signaling pathway (GO:0071526) | 2.41126216 |
| 84 | cellular response to virus (GO:0098586) | 2.40647195 |
| 85 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.38177069 |
| 86 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.37634552 |
| 87 | cell-substrate junction assembly (GO:0007044) | 2.36636504 |
| 88 | negative regulation of phagocytosis (GO:0050765) | 2.35080986 |
| 89 | regulation of necrotic cell death (GO:0010939) | 2.34001393 |
| 90 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.33223958 |
| 91 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.32206086 |
| 92 | pentose-phosphate shunt (GO:0006098) | 2.29660142 |
| 93 | cell-cell junction maintenance (GO:0045217) | 2.29230216 |
| 94 | pinocytosis (GO:0006907) | 2.28659606 |
| 95 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.27362155 |
| 96 | negative regulation of granulocyte differentiation (GO:0030853) | 2.27256801 |
| 97 | negative regulation of skeletal muscle tissue development (GO:0048642) | 2.26978932 |
| 98 | response to host immune response (GO:0052572) | 2.26904565 |
| 99 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.26904565 |
| 100 | modulation by virus of host morphology or physiology (GO:0019048) | 2.25665084 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.24056824 |
| 2 | MYC_22102868_ChIP-Seq_BL_Human | 3.02152149 |
| 3 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.99010646 |
| 4 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.96129199 |
| 5 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.83867342 |
| 6 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.67931979 |
| 7 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.57415110 |
| 8 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.49606681 |
| 9 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.46120111 |
| 10 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.45879142 |
| 11 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.41561241 |
| 12 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.39175119 |
| 13 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.35351363 |
| 14 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.35113085 |
| 15 | RACK7_27058665_Chip-Seq_MCF-7_Human | 2.24413917 |
| 16 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.09371062 |
| 17 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.07515729 |
| 18 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.00365818 |
| 19 | KDM2B_26808549_Chip-Seq_K562_Human | 1.92909593 |
| 20 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.87873097 |
| 21 | MAF_26560356_Chip-Seq_TH1_Human | 1.84110569 |
| 22 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.72121469 |
| 23 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.71703325 |
| 24 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.70618934 |
| 25 | P68_20966046_ChIP-Seq_HELA_Human | 1.65101040 |
| 26 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.64340898 |
| 27 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.64243479 |
| 28 | UTX_26944678_Chip-Seq_JUKART_Human | 1.63908796 |
| 29 | MAF_26560356_Chip-Seq_TH2_Human | 1.60591115 |
| 30 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.60065617 |
| 31 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.59807864 |
| 32 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.57707240 |
| 33 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.57506477 |
| 34 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.54060695 |
| 35 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.53895633 |
| 36 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.49778660 |
| 37 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48909369 |
| 38 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.46915977 |
| 39 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.45728751 |
| 40 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.45372710 |
| 41 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.44399274 |
| 42 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.42402242 |
| 43 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.40414427 |
| 44 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.40192503 |
| 45 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.40032170 |
| 46 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.38993191 |
| 47 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.38875430 |
| 48 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.38331503 |
| 49 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.35969837 |
| 50 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.35761736 |
| 51 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.35698797 |
| 52 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.34558679 |
| 53 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.34153116 |
| 54 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.34134045 |
| 55 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.33913869 |
| 56 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.32192811 |
| 57 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.31915611 |
| 58 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.30126550 |
| 59 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.29461615 |
| 60 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.28730687 |
| 61 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.27436502 |
| 62 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.25383185 |
| 63 | SPI1_23127762_ChIP-Seq_K562_Human | 1.25317040 |
| 64 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.25258370 |
| 65 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.23928076 |
| 66 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.23611094 |
| 67 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.20749579 |
| 68 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.19259966 |
| 69 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.18870460 |
| 70 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.18168304 |
| 71 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.17941740 |
| 72 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.17752637 |
| 73 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.17660569 |
| 74 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.16354834 |
| 75 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.16035497 |
| 76 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12605985 |
| 77 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.11949216 |
| 78 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.10939252 |
| 79 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.10537413 |
| 80 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.09275580 |
| 81 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.09208164 |
| 82 | ATF3_27146783_Chip-Seq_COLON_Human | 1.08833637 |
| 83 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.05721345 |
| 84 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.04446000 |
| 85 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.02653173 |
| 86 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.02153905 |
| 87 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.02062263 |
| 88 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.00845443 |
| 89 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.00518369 |
| 90 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.00470835 |
| 91 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.00440142 |
| 92 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.99994356 |
| 93 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.99093715 |
| 94 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.98819979 |
| 95 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.98745281 |
| 96 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97051732 |
| 97 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.97029748 |
| 98 | GATA1_19941826_ChIP-Seq_K562_Human | 0.96133804 |
| 99 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95879521 |
| 100 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.95780757 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003705_abnormal_hypodermis_morpholog | 3.90364092 |
| 2 | MP0005451_abnormal_body_composition | 3.35448977 |
| 3 | MP0003436_decreased_susceptibility_to | 3.07843353 |
| 4 | MP0003303_peritoneal_inflammation | 2.97986730 |
| 5 | MP0005058_abnormal_lysosome_morphology | 2.74514345 |
| 6 | MP0005076_abnormal_cell_differentiation | 2.54567859 |
| 7 | MP0004510_myositis | 2.36643190 |
| 8 | MP0003300_gastrointestinal_ulcer | 2.32057967 |
| 9 | MP0009278_abnormal_bone_marrow | 2.31324797 |
| 10 | MP0000751_myopathy | 2.27209600 |
| 11 | MP0003172_abnormal_lysosome_physiology | 2.20563074 |
| 12 | MP0008260_abnormal_autophagy | 2.09745190 |
| 13 | MP0004858_abnormal_nervous_system | 2.02519513 |
| 14 | MP0001849_ear_inflammation | 1.90641156 |
| 15 | MP0009840_abnormal_foam_cell | 1.87994628 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 1.87860331 |
| 17 | MP0004185_abnormal_adipocyte_glucose | 1.80665099 |
| 18 | MP0000685_abnormal_immune_system | 1.74937990 |
| 19 | MP0003453_abnormal_keratinocyte_physiol | 1.74925100 |
| 20 | MP0004947_skin_inflammation | 1.73871530 |
| 21 | MP0002419_abnormal_innate_immunity | 1.71081069 |
| 22 | MP0003279_aneurysm | 1.64896087 |
| 23 | MP0003763_abnormal_thymus_physiology | 1.62950600 |
| 24 | MP0005025_abnormal_response_to | 1.61508107 |
| 25 | MP0001790_abnormal_immune_system | 1.57957017 |
| 26 | MP0005387_immune_system_phenotype | 1.57957017 |
| 27 | MP0003091_abnormal_cell_migration | 1.56368124 |
| 28 | MP0003724_increased_susceptibility_to | 1.56045876 |
| 29 | MP0005000_abnormal_immune_tolerance | 1.55577893 |
| 30 | MP0003566_abnormal_cell_adhesion | 1.55280042 |
| 31 | MP0005666_abnormal_adipose_tissue | 1.54142201 |
| 32 | MP0002249_abnormal_larynx_morphology | 1.51179111 |
| 33 | MP0000858_altered_metastatic_potential | 1.46958744 |
| 34 | MP0005409_darkened_coat_color | 1.46938873 |
| 35 | MP0000678_abnormal_parathyroid_gland | 1.46868993 |
| 36 | MP0001533_abnormal_skeleton_physiology | 1.46694834 |
| 37 | MP0000747_muscle_weakness | 1.45899855 |
| 38 | MP0000759_abnormal_skeletal_muscle | 1.45764596 |
| 39 | MP0002877_abnormal_melanocyte_morpholog | 1.45150318 |
| 40 | MP0009333_abnormal_splenocyte_physiolog | 1.44607755 |
| 41 | MP0004381_abnormal_hair_follicle | 1.42890149 |
| 42 | MP0000733_abnormal_muscle_development | 1.42016372 |
| 43 | MP0001835_abnormal_antigen_presentation | 1.41171251 |
| 44 | MP0002998_abnormal_bone_remodeling | 1.38126995 |
| 45 | MP0001800_abnormal_humoral_immune | 1.34279903 |
| 46 | MP0005375_adipose_tissue_phenotype | 1.32730685 |
| 47 | MP0002420_abnormal_adaptive_immunity | 1.30559211 |
| 48 | MP0001819_abnormal_immune_cell | 1.29620057 |
| 49 | MP0002723_abnormal_immune_serum | 1.29184603 |
| 50 | MP0003828_pulmonary_edema | 1.28484882 |
| 51 | MP0002452_abnormal_antigen_presenting | 1.26067914 |
| 52 | MP0008438_abnormal_cutaneous_collagen | 1.25885499 |
| 53 | MP0004087_abnormal_muscle_fiber | 1.25340130 |
| 54 | MP0000750_abnormal_muscle_regeneration | 1.25235175 |
| 55 | MP0001348_abnormal_lacrimal_gland | 1.24592420 |
| 56 | MP0001873_stomach_inflammation | 1.22523299 |
| 57 | MP0001958_emphysema | 1.21069371 |
| 58 | MP0004233_abnormal_muscle_weight | 1.20369399 |
| 59 | MP0002396_abnormal_hematopoietic_system | 1.19035768 |
| 60 | MP0004130_abnormal_muscle_cell | 1.17210737 |
| 61 | MP0010155_abnormal_intestine_physiology | 1.16259112 |
| 62 | MP0010234_abnormal_vibrissa_follicle | 1.13962785 |
| 63 | MP0005670_abnormal_white_adipose | 1.11842035 |
| 64 | MP0003075_altered_response_to | 1.10207393 |
| 65 | MP0002398_abnormal_bone_marrow | 1.09988073 |
| 66 | MP0005464_abnormal_platelet_physiology | 1.08450713 |
| 67 | MP0002148_abnormal_hypersensitivity_rea | 1.06904102 |
| 68 | MP0000749_muscle_degeneration | 1.04846615 |
| 69 | MP0000716_abnormal_immune_system | 1.03174345 |
| 70 | MP0009785_altered_susceptibility_to | 1.02095244 |
| 71 | MP0002405_respiratory_system_inflammati | 1.01653385 |
| 72 | MP0000767_abnormal_smooth_muscle | 1.01475235 |
| 73 | MP0006082_CNS_inflammation | 0.99971646 |
| 74 | MP0000703_abnormal_thymus_morphology | 0.99844556 |
| 75 | MP0010630_abnormal_cardiac_muscle | 0.99492236 |
| 76 | MP0005390_skeleton_phenotype | 0.97805051 |
| 77 | MP0005330_cardiomyopathy | 0.95107386 |
| 78 | MP0000003_abnormal_adipose_tissue | 0.94900719 |
| 79 | MP0002933_joint_inflammation | 0.93274084 |
| 80 | MP0003045_fibrosis | 0.93068134 |
| 81 | MP0002796_impaired_skin_barrier | 0.92996488 |
| 82 | MP0005671_abnormal_response_to | 0.91813727 |
| 83 | MP0005023_abnormal_wound_healing | 0.91767844 |
| 84 | MP0001545_abnormal_hematopoietic_system | 0.91124611 |
| 85 | MP0005397_hematopoietic_system_phenotyp | 0.91124611 |
| 86 | MP0003329_amyloid_beta_deposits | 0.90591492 |
| 87 | MP0003183_abnormal_peptide_metabolism | 0.88942869 |
| 88 | MP0002429_abnormal_blood_cell | 0.87576041 |
| 89 | MP0002722_abnormal_immune_system | 0.87009664 |
| 90 | MP0002106_abnormal_muscle_physiology | 0.86195926 |
| 91 | MP0006138_congestive_heart_failure | 0.85181936 |
| 92 | MP0001851_eye_inflammation | 0.83540377 |
| 93 | MP0004808_abnormal_hematopoietic_stem | 0.83121541 |
| 94 | MP0001845_abnormal_inflammatory_respons | 0.82930373 |
| 95 | MP0005166_decreased_susceptibility_to | 0.81683798 |
| 96 | MP0004036_abnormal_muscle_relaxation | 0.77399278 |
| 97 | MP0003448_altered_tumor_morphology | 0.76966343 |
| 98 | MP0005310_abnormal_salivary_gland | 0.75712193 |
| 99 | MP0002060_abnormal_skin_morphology | 0.75452723 |
| 100 | MP0002332_abnormal_exercise_endurance | 0.74746341 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Obstructive sleep apnea (HP:0002870) | 3.58000566 |
| 2 | Increased connective tissue (HP:0009025) | 3.54805409 |
| 3 | Eczematoid dermatitis (HP:0000976) | 3.35816748 |
| 4 | Distal lower limb amyotrophy (HP:0008944) | 3.20431672 |
| 5 | Type 1 muscle fiber predominance (HP:0003803) | 3.13759625 |
| 6 | Myopathic facies (HP:0002058) | 3.07216408 |
| 7 | Distal lower limb muscle weakness (HP:0009053) | 3.06627765 |
| 8 | Exercise-induced myalgia (HP:0003738) | 3.06038663 |
| 9 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.02495966 |
| 10 | Increased variability in muscle fiber diameter (HP:0003557) | 2.90164650 |
| 11 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.89977166 |
| 12 | Broad face (HP:0000283) | 2.82697769 |
| 13 | Hyperacusis (HP:0010780) | 2.75938875 |
| 14 | Cerebral aneurysm (HP:0004944) | 2.73602936 |
| 15 | Muscle fiber inclusion bodies (HP:0100299) | 2.60866704 |
| 16 | Cellulitis (HP:0100658) | 2.57457402 |
| 17 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.54549742 |
| 18 | Round ear (HP:0100830) | 2.48937745 |
| 19 | Asymmetric septal hypertrophy (HP:0001670) | 2.48269944 |
| 20 | Easy fatigability (HP:0003388) | 2.47443065 |
| 21 | Protrusio acetabuli (HP:0003179) | 2.46936987 |
| 22 | Nemaline bodies (HP:0003798) | 2.45810195 |
| 23 | Abnormality of macrophages (HP:0004311) | 2.44762401 |
| 24 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.36006316 |
| 25 | Stridor (HP:0010307) | 2.34722737 |
| 26 | Recurrent abscess formation (HP:0002722) | 2.33542350 |
| 27 | Achilles tendon contracture (HP:0001771) | 2.31639828 |
| 28 | Increased IgE level (HP:0003212) | 2.30067905 |
| 29 | Ulnar deviation of the wrist (HP:0003049) | 2.26018073 |
| 30 | Thin bony cortex (HP:0002753) | 2.25420290 |
| 31 | Difficulty climbing stairs (HP:0003551) | 2.24643921 |
| 32 | Difficulty running (HP:0009046) | 2.22127803 |
| 33 | Ulnar bowing (HP:0003031) | 2.21657913 |
| 34 | Bulbar palsy (HP:0001283) | 2.21305438 |
| 35 | Recurrent bacterial skin infections (HP:0005406) | 2.21162379 |
| 36 | Muscle fiber splitting (HP:0003555) | 2.20393629 |
| 37 | Lower limb amyotrophy (HP:0007210) | 2.20139110 |
| 38 | Hemorrhage of the eye (HP:0011885) | 2.19373687 |
| 39 | Dysostosis multiplex (HP:0000943) | 2.11646262 |
| 40 | Disproportionate tall stature (HP:0001519) | 2.11140516 |
| 41 | Obstructive lung disease (HP:0006536) | 2.07940856 |
| 42 | Chronic obstructive pulmonary disease (HP:0006510) | 2.07940856 |
| 43 | Distal upper limb amyotrophy (HP:0007149) | 2.07780287 |
| 44 | Upper limb amyotrophy (HP:0009129) | 2.07780287 |
| 45 | Slender build (HP:0001533) | 2.04821077 |
| 46 | Axonal loss (HP:0003447) | 2.03402552 |
| 47 | Vertebral compression fractures (HP:0002953) | 2.03332132 |
| 48 | Abnormality of the Achilles tendon (HP:0005109) | 2.02194340 |
| 49 | Hyporeflexia of lower limbs (HP:0002600) | 1.99102072 |
| 50 | Gingivitis (HP:0000230) | 1.96900417 |
| 51 | Myositis (HP:0100614) | 1.95770861 |
| 52 | Emphysema (HP:0002097) | 1.95647408 |
| 53 | Cervical subluxation (HP:0003308) | 1.94594829 |
| 54 | Spinal rigidity (HP:0003306) | 1.94177459 |
| 55 | Premature rupture of membranes (HP:0001788) | 1.92287688 |
| 56 | Fragile skin (HP:0001030) | 1.91288983 |
| 57 | Aneurysm (HP:0002617) | 1.90555738 |
| 58 | Colitis (HP:0002583) | 1.88316930 |
| 59 | Mitral regurgitation (HP:0001653) | 1.87906521 |
| 60 | Increased cerebral lipofuscin (HP:0011813) | 1.86642070 |
| 61 | Long palpebral fissure (HP:0000637) | 1.85895872 |
| 62 | Shallow orbits (HP:0000586) | 1.83539124 |
| 63 | Gastrointestinal inflammation (HP:0004386) | 1.83465932 |
| 64 | EMG: myopathic abnormalities (HP:0003458) | 1.82938242 |
| 65 | Abnormality of the fingertips (HP:0001211) | 1.81402002 |
| 66 | Spontaneous hematomas (HP:0007420) | 1.80635616 |
| 67 | Gastrointestinal infarctions (HP:0005244) | 1.80337974 |
| 68 | Mediastinal lymphadenopathy (HP:0100721) | 1.78709678 |
| 69 | Abnormality of the thoracic spine (HP:0100711) | 1.78288776 |
| 70 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.77068485 |
| 71 | Dilatation of the ascending aorta (HP:0005111) | 1.76545561 |
| 72 | Genu recurvatum (HP:0002816) | 1.75995190 |
| 73 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.75866396 |
| 74 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.75866396 |
| 75 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.75866396 |
| 76 | Gastrointestinal stroma tumor (HP:0100723) | 1.74654925 |
| 77 | Polygenic inheritance (HP:0010982) | 1.74286549 |
| 78 | Abnormality of glycolipid metabolism (HP:0010969) | 1.72265927 |
| 79 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.72265927 |
| 80 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.72265927 |
| 81 | Metaphyseal cupping (HP:0003021) | 1.71652686 |
| 82 | Hypertriglyceridemia (HP:0002155) | 1.70269810 |
| 83 | Orchitis (HP:0100796) | 1.70103320 |
| 84 | Mucopolysacchariduria (HP:0008155) | 1.69717854 |
| 85 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.69717854 |
| 86 | Meningitis (HP:0001287) | 1.69143963 |
| 87 | Generalized amyotrophy (HP:0003700) | 1.68895212 |
| 88 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.68875419 |
| 89 | J-shaped sella turcica (HP:0002680) | 1.68614600 |
| 90 | Hypertensive crisis (HP:0100735) | 1.67999158 |
| 91 | Thin ribs (HP:0000883) | 1.66227266 |
| 92 | Loss of speech (HP:0002371) | 1.65787124 |
| 93 | Nuclear cataract (HP:0100018) | 1.64780127 |
| 94 | Slow saccadic eye movements (HP:0000514) | 1.62803379 |
| 95 | Hypercortisolism (HP:0001578) | 1.62144531 |
| 96 | Polycythemia (HP:0001901) | 1.61683488 |
| 97 | Annular pancreas (HP:0001734) | 1.60578833 |
| 98 | Blue sclerae (HP:0000592) | 1.60400978 |
| 99 | Joint stiffness (HP:0001387) | 1.60078179 |
| 100 | Inflammation of the large intestine (HP:0002037) | 1.59169069 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 4.30979179 |
| 2 | PRPF4B | 3.63035629 |
| 3 | SIK1 | 3.62903996 |
| 4 | ERN1 | 3.37430659 |
| 5 | SMG1 | 2.55588332 |
| 6 | TTN | 2.43976934 |
| 7 | MAP4K1 | 2.34827624 |
| 8 | IRAK3 | 2.25843302 |
| 9 | MAP2K3 | 2.23667857 |
| 10 | ICK | 2.20350874 |
| 11 | RIPK4 | 1.95066887 |
| 12 | EEF2K | 1.87663276 |
| 13 | RIPK1 | 1.80988514 |
| 14 | CDK12 | 1.75177704 |
| 15 | IRAK4 | 1.70016371 |
| 16 | MAP3K10 | 1.67385654 |
| 17 | EPHB1 | 1.60360519 |
| 18 | TAOK2 | 1.55916577 |
| 19 | TAOK1 | 1.55671130 |
| 20 | MAP3K11 | 1.53832623 |
| 21 | TNK2 | 1.53403650 |
| 22 | MARK2 | 1.43075746 |
| 23 | PRKD2 | 1.37798475 |
| 24 | MAP3K13 | 1.37343609 |
| 25 | MAP3K3 | 1.36187961 |
| 26 | PKN2 | 1.30409898 |
| 27 | FGFR4 | 1.27287097 |
| 28 | EPHA2 | 1.25349132 |
| 29 | CDC42BPA | 1.22399949 |
| 30 | SIK2 | 1.19402113 |
| 31 | SIK3 | 1.18234915 |
| 32 | TBK1 | 1.16701387 |
| 33 | TYK2 | 1.15930702 |
| 34 | MAP3K1 | 1.15260615 |
| 35 | PTK6 | 1.15114623 |
| 36 | ZAP70 | 1.13818066 |
| 37 | IRAK2 | 1.11108914 |
| 38 | BLK | 1.07554354 |
| 39 | KSR2 | 1.03827021 |
| 40 | MAPK12 | 1.02169775 |
| 41 | MAP3K7 | 1.01893854 |
| 42 | CSK | 1.01481611 |
| 43 | GRK6 | 1.01302387 |
| 44 | NME2 | 0.95508252 |
| 45 | PRKD3 | 0.93768048 |
| 46 | HIPK2 | 0.93437502 |
| 47 | PDPK1 | 0.92009802 |
| 48 | MTOR | 0.86294252 |
| 49 | MAP3K14 | 0.85304036 |
| 50 | TESK1 | 0.85100722 |
| 51 | PDGFRA | 0.83799858 |
| 52 | RPS6KA2 | 0.81777914 |
| 53 | RPS6KL1 | 0.80313674 |
| 54 | RPS6KC1 | 0.80313674 |
| 55 | PAK4 | 0.79043074 |
| 56 | MAP3K6 | 0.78467150 |
| 57 | MST1R | 0.77986103 |
| 58 | FES | 0.77821839 |
| 59 | BTK | 0.72274495 |
| 60 | BMX | 0.70055276 |
| 61 | ARAF | 0.68479634 |
| 62 | JAK3 | 0.68290484 |
| 63 | MAPK7 | 0.67024605 |
| 64 | HCK | 0.66410792 |
| 65 | MAP2K2 | 0.66025093 |
| 66 | PDK1 | 0.64366731 |
| 67 | MAPK11 | 0.64360524 |
| 68 | TESK2 | 0.61961881 |
| 69 | LMTK2 | 0.61130209 |
| 70 | RPS6KA6 | 0.58691201 |
| 71 | DYRK1B | 0.56991898 |
| 72 | DDR2 | 0.56813539 |
| 73 | CSF1R | 0.56146582 |
| 74 | PRKG2 | 0.53668024 |
| 75 | CDK4 | 0.52224057 |
| 76 | PTK2 | 0.51591899 |
| 77 | OBSCN | 0.51221186 |
| 78 | CAMKK1 | 0.51167115 |
| 79 | MOS | 0.49657261 |
| 80 | PHKG2 | 0.47200533 |
| 81 | PHKG1 | 0.47200533 |
| 82 | MAPK4 | 0.46920248 |
| 83 | STK38 | 0.46798319 |
| 84 | JAK1 | 0.46499810 |
| 85 | MAP3K8 | 0.46146704 |
| 86 | LRRK2 | 0.46126343 |
| 87 | BRAF | 0.43602013 |
| 88 | IKBKE | 0.42782109 |
| 89 | MAP2K6 | 0.40845036 |
| 90 | FGR | 0.40538987 |
| 91 | SGK3 | 0.40077049 |
| 92 | MAPKAPK2 | 0.39370422 |
| 93 | DMPK | 0.38936334 |
| 94 | CAMK1D | 0.38241199 |
| 95 | RET | 0.38191116 |
| 96 | TYRO3 | 0.38172378 |
| 97 | IKBKB | 0.37890323 |
| 98 | CHUK | 0.37886138 |
| 99 | RPS6KA1 | 0.37472332 |
| 100 | IRAK1 | 0.36965741 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 2.29028617 |
| 2 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 2.21040239 |
| 3 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.02786615 |
| 4 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.95804621 |
| 5 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.95457902 |
| 6 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.83685450 |
| 7 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.82578463 |
| 8 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.74176719 |
| 9 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.71972597 |
| 10 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.68139992 |
| 11 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.67241579 |
| 12 | Leishmaniasis_Homo sapiens_hsa05140 | 1.63856703 |
| 13 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.54302171 |
| 14 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.47196933 |
| 15 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.35927138 |
| 16 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.35788381 |
| 17 | Bladder cancer_Homo sapiens_hsa05219 | 1.33797571 |
| 18 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.29381123 |
| 19 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.27256287 |
| 20 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.25629217 |
| 21 | Tuberculosis_Homo sapiens_hsa05152 | 1.24708360 |
| 22 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.24588800 |
| 23 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.22448672 |
| 24 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.21494400 |
| 25 | Endometrial cancer_Homo sapiens_hsa05213 | 1.20815290 |
| 26 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.20025561 |
| 27 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.19358294 |
| 28 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.18095699 |
| 29 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.16668726 |
| 30 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.16331401 |
| 31 | Prion diseases_Homo sapiens_hsa05020 | 1.10822953 |
| 32 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.09621284 |
| 33 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.08581499 |
| 34 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.07586793 |
| 35 | Hepatitis B_Homo sapiens_hsa05161 | 1.07430992 |
| 36 | Influenza A_Homo sapiens_hsa05164 | 1.06951434 |
| 37 | Glioma_Homo sapiens_hsa05214 | 1.06349981 |
| 38 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.05982449 |
| 39 | Hepatitis C_Homo sapiens_hsa05160 | 1.05936397 |
| 40 | Malaria_Homo sapiens_hsa05144 | 1.04276080 |
| 41 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.03981448 |
| 42 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.03059690 |
| 43 | Viral myocarditis_Homo sapiens_hsa05416 | 1.02171029 |
| 44 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.01859458 |
| 45 | Insulin resistance_Homo sapiens_hsa04931 | 1.01838041 |
| 46 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.00377890 |
| 47 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.99654063 |
| 48 | Amoebiasis_Homo sapiens_hsa05146 | 0.99313266 |
| 49 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.98464400 |
| 50 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.97397743 |
| 51 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.97017040 |
| 52 | Focal adhesion_Homo sapiens_hsa04510 | 0.95619389 |
| 53 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.95563159 |
| 54 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.92922598 |
| 55 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.92251650 |
| 56 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.91472483 |
| 57 | Thyroid cancer_Homo sapiens_hsa05216 | 0.90874537 |
| 58 | Measles_Homo sapiens_hsa05162 | 0.89673020 |
| 59 | Lysosome_Homo sapiens_hsa04142 | 0.88471430 |
| 60 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.88300058 |
| 61 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.88292287 |
| 62 | Apoptosis_Homo sapiens_hsa04210 | 0.87600545 |
| 63 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.87407705 |
| 64 | Endocytosis_Homo sapiens_hsa04144 | 0.86828798 |
| 65 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.86744782 |
| 66 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.84759183 |
| 67 | Salmonella infection_Homo sapiens_hsa05132 | 0.83720948 |
| 68 | HTLV-I infection_Homo sapiens_hsa05166 | 0.83357644 |
| 69 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.81296822 |
| 70 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.80574706 |
| 71 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.80172338 |
| 72 | Platelet activation_Homo sapiens_hsa04611 | 0.78829126 |
| 73 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.78605696 |
| 74 | Shigellosis_Homo sapiens_hsa05131 | 0.78594642 |
| 75 | Colorectal cancer_Homo sapiens_hsa05210 | 0.76952119 |
| 76 | Long-term potentiation_Homo sapiens_hsa04720 | 0.76632630 |
| 77 | Galactose metabolism_Homo sapiens_hsa00052 | 0.75379559 |
| 78 | Prostate cancer_Homo sapiens_hsa05215 | 0.74141277 |
| 79 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.73706721 |
| 80 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.73135120 |
| 81 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.72375221 |
| 82 | Pertussis_Homo sapiens_hsa05133 | 0.71665682 |
| 83 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.69237844 |
| 84 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.68673215 |
| 85 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.67113411 |
| 86 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.66211197 |
| 87 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.65867158 |
| 88 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.65447526 |
| 89 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.65079049 |
| 90 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.65047997 |
| 91 | Allograft rejection_Homo sapiens_hsa05330 | 0.64560741 |
| 92 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.63354743 |
| 93 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.60724754 |
| 94 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.57436221 |
| 95 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.55670591 |
| 96 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.55419336 |
| 97 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.55399354 |
| 98 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.54220258 |
| 99 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.54168853 |
| 100 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.53332467 |

